2015
DOI: 10.1016/j.ijcard.2014.03.210
|View full text |Cite
|
Sign up to set email alerts
|

The instantaneous wave-free ratio (iFR) for evaluation of non-culprit lesions in patients with acute coronary syndrome and multivessel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
29
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 38 publications
(30 citation statements)
references
References 53 publications
1
29
0
Order By: Relevance
“…Reproduced with permission from Petraco R, et al 66 Current Developments in Pressure-Only Indices stenoses in 82 patients with ACS and stable disease, an iFR threshold of 0.92 best matched an FFR of 0.80 with a diagnostic concordance with FFR of 81.3%. 71 No difference in diagnostic efficiency between ACS patients and those with stable disease was found and all apparent discrepancies were within the FFR 0.75-0.80 gray-zone. 71 Furthermore, when using a hybrid iFR-FFR approach, they found 68% of patients would be spared adenosine.…”
Section: Clinical Application Of Ifr: Using the Ifr-ffr Hybrid Approachmentioning
confidence: 82%
See 2 more Smart Citations
“…Reproduced with permission from Petraco R, et al 66 Current Developments in Pressure-Only Indices stenoses in 82 patients with ACS and stable disease, an iFR threshold of 0.92 best matched an FFR of 0.80 with a diagnostic concordance with FFR of 81.3%. 71 No difference in diagnostic efficiency between ACS patients and those with stable disease was found and all apparent discrepancies were within the FFR 0.75-0.80 gray-zone. 71 Furthermore, when using a hybrid iFR-FFR approach, they found 68% of patients would be spared adenosine.…”
Section: Clinical Application Of Ifr: Using the Ifr-ffr Hybrid Approachmentioning
confidence: 82%
“…71 No difference in diagnostic efficiency between ACS patients and those with stable disease was found and all apparent discrepancies were within the FFR 0.75-0.80 gray-zone. 71 Furthermore, when using a hybrid iFR-FFR approach, they found 68% of patients would be spared adenosine. Further data will come from the DEFINE-FLAIR study, which is including patients with ACS.…”
Section: Clinical Application Of Ifr: Using the Ifr-ffr Hybrid Approachmentioning
confidence: 82%
See 1 more Smart Citation
“…During the assessment of eligibility, further 6 studies were excluded. 8,[30][31][32][33][34] Finally, a total of 23 studies were available for the analysis, 7,[9][10][11][12][13][14][15][16][17][18][19][20][21]28,29,[35][36][37][38][39][40][41] including 6381 stenoses. The study selection procedure is reported in details in Figure 1 while the Table summarizes the most relevant characteristics of the selected studies.…”
Section: Resultsmentioning
confidence: 99%
“…Further key elements in the decision-making process for treating ULMCA disease that are missing in the article by Mahmoud and colleagues but are well worth a mention are: (I) the known difference in terms of technical execution and clinical outcome for PCI between stenting of the LM ostium or trunk and the treatment of bifurcation or trifurcation lesions, that are associated with a higher rate of restenosis, while lesion location has no relevant influence on long-term results of CABG; (II) the angiographic definition of "significant" ULMCA disease remains challenging, whereas intracoronary evaluation techniques such as intracoronary imaging (IVUS/OCT) or iFR/FFR might be very helpful in this setting (15)(16)(17)(18); (III) PCI techniques to treat the stenosis of ULMCA are different and quite heterogeneous, and we know that implantation techniques have a significant impact on clinical results for PCI of a ULMCA (18); (IV) in our recent meta-regression analysis, older patients did better with PCI than CABG (12).…”
mentioning
confidence: 99%